AstraZeneca · 4 months ago
Executive Director, Portfolio Strategy & Business Development - OBU Strategy
US - Gaithersburg - MD
Full-time
Onsite
Director/Executive
$270K/yr - $405K/yr
15+ years expAstraZeneca is a leading biopharmaceutical company focused on innovation in oncology. The Executive Director will lead strategy for the oncology pipeline, collaborating with R&D to deliver therapies that improve patient outcomes while managing a high-performing team.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Leads the development and implementation of Business Unit therapy area, multi-brand or brand-agnostic strategies that integrate into one company-wide oncology strategy built with counterparts in global franchises and oncology R&D
Drives portfolio strategic initiatives that enhance AZ’s competitiveness and deliver sustainable growth
Frequently engages with C-Suite level leaders (SET and SET-1) to provide disciplined insights-driven valuations and strategies
Drives clarity and consistency across priority business processes in major governance forums. These include investment decisions, TA Strategy/Portfolio reviews and long range plans across the specific tumour portfolios
Engages with Finance VPs to ensure robust assessment of value in annual impairment review (key audit process)
Leads the portfolio team in delivery of the commercial analysis, business development valuations, forecasting, market research and insight generation to shape and deliver OBU priorities: R&D decisions, supply planning and TA scenario analysis – including leadership of other team members working across the OBU Strategy team. You will work closely with the tumor area heads in OBU Strategy to do this
Understanding and communication of complex study design, TPPs, CDP’s, combination approaches, competition, pricing, prioritization, and decision making considerations expected in the context of our competitors’ strategies
Managing large investment requests and business development opportunity assessments with extreme confidentiality, quality and rigor for consistency in approach
Influence with and without authority a large number of senior stakeholders (SET, SET-1, SET-2) across OBU and ORD and criss-crossing tumour and asset alignment meetings
Monitor market trends, competitive dynamics, and emerging science to inform strategic planning and business development priorities
Support Head of OBU Strategy to coordinate, oversee and integrate all tumor into one portfolio strategy
Collaborate closely with Corporate Development, Finance, and R&D to support deal negotiations and integration planning
Guide and direct team members at the director and associate director level
Maintain trusted partnering, credibility and collaboration with clinical, commercial and strategy leaders
Qualification
Required
Bachelor's degree
15 years of relevant industry experience (or MBA/PhD with 10 years of relevant experience)
Extensive experience in oncology +/- haematology
Strong consultative and communication skills
A strong scientific background and strategic analytical skills
Industry or consulting experience in pharmaceutical pipeline strategy (market assessment, competitor analysis, forecasting)
Excellent analysis and fact-based decision-making
Experience with data and/or a science research/bio-pharmaceutical environment
Motivated by working in a fast-paced field with clear societal impact
Understanding of general business and core marketing principles and application to future healthcare market challenges
Familiar with the oncology drug development process and necessary strategic and commercial touch points
Prior experience managing direct reports
Able to influence without authority and establish and maintain credibility with senior audiences
Resourceful, motivated, decisive and proactive; must be able to manage multiple priorities in a fast-growing organization
Attention to detail while also a big picture thinker & communicator
A critical thinker with experience of identifying and driving key projects and providing researched, verified, relevant information to leaders
Preferred
MBA or PhD with 10 years of relevant experience
Experience of setting up short- and long-term strategic plans
Understanding of clinical data and clinical trial design
Experience in at least two major geographies (e.g. US, EU, Japan, China)
Experience in cell therapy and/or radioconjugates
Thorough understanding of regulatory and pricing dynamics in major markets
Comfortable with AI and utilizing AI to support ethical and accurate analyses of data
Benefits
Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Pascal Soriot
Executive Director and Chief Executive Officer
Aradhana Sarin
Group CFO and Executive Director
Recent News
Essential Business
2026-01-24
2026-01-23
Company data provided by crunchbase